Enwei Pharmaceutical Co., Ltd.

¥21.79As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301331Healthcare
Country China
PE (Fwd) •••
TSR 4Y CAGR (7.93%)
Div yield 4.73%
ROE 3.58%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.56
PE TTM 60.75
TSR TTM (26.56%)
Mkt cap ¥2.220B
ROIC 4.42%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥23
7.09%
(62.32%)
Hold 12|12|4|0|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.26
0.25
0.24
0.24
1.55%
3.09%
(2.93%)
(10.00%)
Revenue¥M
252.8
256.9
249.7
249.5
4.33%
3.28%
(4.70%)
(2.22%)
Peers (US$332.8M)
Cap (US$)
PE
332.8M
—
Capital
TTM
5Y
10Y
Leveragex
0.567
0.049
0.047
EBIT/Intx
0.249
0.153
0.135
Own earn%
96.79
7.88
14.12
Sh yield%
55.61
42.06
41.99
Owners
Insiders/Inst%
6.59
25.14
Short interest%
4.55
SBC / revenue%
5.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
4–13
$1 testx
−0.3
Incr. ROIC%
2